Skip to main content

Table 4 Single dose adults—antibodies (log10 mIU/mL)—by time interval

From: Validation of a yellow fever vaccine model using data from primary vaccination in children and adults, re-vaccination and dose-response in adults and studies with immunocompromised individuals

Categorical time Number of individuals Average time (days) GMT (\(\text {log}_{10}\) mIU/mL)
NV (0) 46 0 1.96
PV (30–45 days) 46 44 (42–49) 3.88
PV (1–5 years) 36 1367 (537–1833) 3.40
PV (5–9 years) 12 2609 (1882–3406) 3.40
PV (> 10 years) 45 4081 (3721–4414) 3.19